Nutriband Inc. NTRB

FY2026 · ended Jan 31, 2026 · Revenue $2.04M, -4.8% YoY · Filed Apr 29, 2026

Nutriband Inc. (NTRB) files with the SEC under industry code 3842, Orthopedic, Prosthetic & Surgical Appliances & Supplies. In fiscal 2026, which ended Jan 31, 2026, it reported revenue of $2.0 million and a net loss of $8.2 million. Free cash flow was -$5.1 million. As of Jul 31, 2026 it held $3.4 million in cash and investments and $66,178 in total debt.

Revenue (TTM)
$1.62M
Net income (TTM)
$-6.96M
Operating cash flow (TTM)
$-3.63M
Free cash flow
$-5.14M
-8.9% vs prior year
EPS (TTM)
$-0.57
Dividend per share
None
Shares outstanding
0
-100.0% vs prior year
Net cash
$3.36M
as of Jul 31, 2026
Operating margin
-435.6%
FY 2027

Company profile

Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
Listed as
NTRB (Nasdaq)
Fiscal year ends
January 31
Incorporated in
NV
Headquarters
Orlando, FL
SEC filer status
, Emerging growth company
SEC CIK
1676047

Other Orthopedic, Prosthetic & Surgical Appliances & Supplies companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2026
Jan 31, 2026
FY 2025
Jan 31, 2025
FY 2024
Jan 31, 2024
FY 2023
Jan 31, 2023
FY 2022
Jan 31, 2022
Revenue
$2.0M
$2.1M
$2.1M
$2.1M
$1.2M
Operating income
-$8.3M
-$10.3M
-$4.9M
-$4.5M
-$6.1M
Net income
-$8.2M
-$10.5M
-$5.5M
-$4.5M
-$6.2M
Diluted EPS
-$2.58
-$0.99
-$0.69
-$0.53
—
Operating cash flow
-$5.1M
-$4.6M
-$3.5M
-$3.0M
-$2.8M
Free cash flow
-$5.1M
-$4.7M
-$3.6M
-$3.1M
-$2.9M
Total assets
$7.5M
$7.5M
$7.5M
$9.5M
$12.7M
Total liabilities
$868,447
$1.0M
$1.1M
$883,387
$880,375
Stockholders' equity
$6.7M
$6.4M
$6.4M
$8.6M
$11.9M
Cash and investments
$4.6M
$4.3M
$492,942
$2.0M
$4.9M
Total debt
$80,758
—
$34,276
$99,845
$19,331

Recent SEC filings

Recent SEC filings
Form Description Filed Period
8-K Current report
Regulation FD disclosure
Sep 23, 2026 Sep 21, 2026
10-Q Quarterly report Sep 4, 2026 Jul 31, 2026
8-K Current report
Material agreement
Jun 22, 2026 Jun 1, 2026
10-Q Quarterly report Jun 11, 2026 Apr 30, 2026
10-K/A Amended annual report May 18, 2026 Jan 31, 2026
10-K Annual report Apr 29, 2026 Jan 31, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.